📰 Device Designation News
Page 22 - Device Designation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Device Designation. Real-time updates on events, politics, business and more.
October 12, 2021
/PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in intensive care and cardiac surgery using...
October 11, 2021
Alpha DaRT has received FDA breakthrough designation for the treatment of patients with recurrent glioblastoma multiform (GBM).
October 8, 2021
/PRNewswire/ -- Alpha Tau Medical, the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, is pleased to announce that it has received...
October 8, 2021
Read the latest Food and Drug Administration headlines - updated 24/7/365. We link to the best sources from around the world. Get the latest on the FDA...
October 7, 2021
Amprion has announced the commercial rollout of its innovative SYNTap Biomarker Test, a first-in-class laboratory-developed test (LDT) for accurate...
October 7, 2021
Read the latest Breakthrough Infections headlines - updated 24/7/365. Get the latest on Covid-19 Breakthrough Infections...
October 6, 2021
San Francisco, CA (PRWEB) October 06, 2021 -- Amprion has announced the commercial rollout of its innovative SYNTap Biomarker Test, a first-in-class
October 6, 2021
The $2.7M Commercialization Readiness Pilot grant, awarded as part of the Small Business Innovation Research Program, will be used to help commercialize OsteoBoost, an osteopenia treatment and osteoporosis prevention device.
October 6, 2021
The system uses virtual reality and an AI-backed tool.